Abbott Laboratories (ABT) Other financing activities (2016 - 2022)

Abbott Laboratories has disclosed Other financing activities across 7 years of filings, most recently posting $324.0 million for Q1 2022.

• Other financing activities for Q1 2022 came in at $324.0 million, up 6.58% year-over-year; the trailing twelve-month figure through Sep 2025 was $324.0 million (up 427.27% YoY), and the FY2025 annual result was -$82.0 million, changed N/A from the prior year.
• Other financing activities came in at $324.0 million for Q1 2022 at Abbott Laboratories, up from -$536.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $324.0 million in Q1 2022 to a low of -$536.0 million in Q4 2021.
• The 5-year median for Other financing activities is $105.5 million (2019), against an average of $110.9 million.
• Across the five-year window, Other financing activities tumbled 79.65% in 2018 and rose 24.08% in 2021, its largest moves.
• Abbott Laboratories' Other financing activities stood at $81.0 million in 2018, then increased by 4.94% to $85.0 million in 2019, then increased by 18.82% to $101.0 million in 2020, then slumped by 630.69% to -$536.0 million in 2021, then surged by 160.45% to $324.0 million in 2022.
• The last three Other financing activities figures came in at $324.0 million (Q1 2022), -$536.0 million (Q4 2021), and $113.0 million (Q3 2021), per Business Quant data.